menu
    • menu
    [{"orgOrder":0,"company":"Lonza Inc & Lonza America Inc","sponsor":"Context Therapeutics","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"U.S.A","productType":"Large molecule","year":"2023","type":"Agreement","leadProduct":"CTIM-76","moa":"","graph1":"Oncology","graph2":"Preclinical","graph3":"Lonza Inc & Lonza America Inc","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"","sponsorNew":"Lonza Inc & Lonza America Inc \/ Lonza Inc & Lonza America Inc","highestDevelopmentStatusID":"4","companyTruncated":"Lonza Inc & Lonza America Inc \/ Lonza Inc & Lonza America Inc"}]

    Find Clinical Drug Pipeline Developments & Deals by Lonza Inc & Lonza America Inc

    Menu

    Lonza Inc & Lonza America Inc

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
    filter

    Year

    filter

    DEALS // DEV.

    filter

    Country

    filter
    Sponsor
    filter

    Therapeutic Area

    filter

    Study Phase

    filter

    Deal Type

    filter

    Product Type

    filter

    Dosage Form

    filter

    Lead Product

    filter

    Target

    refresh Filters
    refresh Reset Filter
    refresh Reset Filter
    price-trend All Developments

    Therapeutic Area by Lead Product

    ForexGraph

    Study Phase by Lead Product

    ForexGraph

    Company by Lead Product

    ForexGraph

    Top Deals by Deal Size (USD bn)

    ForexGraph

    01

    Lonza Inc & Lonza America Inc

    U.S.A arrow
    ICHH-25
    Not Confirmed

    Lonza Inc & Lonza America Inc

    U.S.A arrow
    ICHH-25
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : CTIM-76

    Therapeutic Area : Oncology

    Study Phase : Preclinical

    Recipient : Context Therapeutics

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Context Therapeutics and Lonza Enter Manufacturing Agreement for Bispecific Antibody Targeting Claudin 6-Posit...

    Details : Under the agreement, Lonza will support the development and manufacturing of CTIM-76, a CLDN6 x CD3 bispecific antibody clinical candidate. The bispecific antibody-based therapy is being developed to redirect T-cell mediated lysis toward malignant cells ...

    Product Name : CTIM-76

    Product Type : Large molecule

    Upfront Cash : Undisclosed

    January 09, 2023

    Lead Product(s) : CTIM-76

    Therapeutic Area : Oncology

    Highest Development Status : Preclinical

    Recipient : Context Therapeutics

    Deal Size : Undisclosed

    Deal Type : Agreement

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth